Opox-CV 100DT 10 Tablets

Babies: Not applicable. Lactating mother: Cefpodoxime proxetil and clavulanic acid tablets are safe to use during breastfeeding.
Human studies have shown that this drug does not pass into the breastmilk and is not harmful to the baby. Pregnancy: Animal studies have suggested that this drug does not cause any harmful effects on developing babies.
Hence, it is safe to use this drug during pregnancy. Alcohol: It is not known whether it is safe to drink alcohol with cefpodoxime proxetil, clavulanic acid tablet.
Consult your doctor. Driving: Cefpodoxime proxetil and clavulanic acid tablets may cause side effects such as allergic reactions, dizziness, and it can affect your ability to drive.
Do not drive if these symptoms occur. Kidney: Cefpodoxime proxetil and clavulanic acid tablets should be used with caution in patients with kidney disease.
Dose adjustment is required. Consult your doctor.
Liver: Consult your doctor before using this drug if you have any liver disease..

Nausea Vomiting Diarrhea Indigestion.

OPOX-CV is a 3rd generation cephalosporin antibiotic. It works by stopping the growth of bacteria.
Clavulanic acid is a beta-lactamase inhibitor. It works by reducing the resistance and increases the activity of cefpodoxime proxetil against bacteria..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Opox-cv tablets are used to treat respiratory tract infection • It can be taken with food and drink plenty of water or fluids to prevent stomach discomforts • Medication should not be stopped unless told by your doctor, even if you feel better • Drink plenty of water to prevent dehydration • Consult your doctor if you experience any blood stools or abdominal cramps because this drug may cause diarrhoea • Probiotics should be taken along with this medication • Consult your doctor if you find any itchy, rash, swelling of the face, throat, or tongue, and breathing difficulties while taking this medication.

• Cefpodoxime proxetil + Desogestrel: Concurrent use may result in decreased contraceptive effectiveness. • Cefpodoxime proxetil + Warfarin: Concurrent use may result in an increased risk of bleeding. • Cefpodoxime proxetil + Norgestimate: Concurrent use may result in decreased contraceptive effectiveness. • Cefpodoxime proxetil + Aluminum hydroxide: Concurrent use may result in decreased cefpodoxime effectiveness. • Clavulanic acid + Acenocumarol: Concurrent use may result in an increased risk of bleeding. • Clavulanic acid + Bcg vaccine: Concurrent use may decrease the therapeutic efficacy of the bcg vaccine. • Clavulanic acid + Dicoumarol: Concurrent use may result in an increased risk of bleeding. • Clavulanic acid + Methotrexate: Concurrent use may result in an increased risk of hepatotoxicity..